Barclays’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Barclays’s Portfolio RNA Stock Details RNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-150,000	Closed	-$2.7M	–	7510
2014 Q4	$2.7M	Hold	150,000	–	–	﹤0.01%	2255
2014 Q3	$1.2M	Buy	+150,000	New	+$1.42M	﹤0.01%	3142
2014 Q2	–	Sell	-8,600	Closed	-$43K	–	8013
2014 Q1	$43K	Sell	8,600 -4,000	-32%	-$24.8K	﹤0.01%	6131
2013 Q4	$50K	Buy	+12,600	New	+$57.4K	﹤0.01%	6188

Barclays's RNA Position: Q1 2015 in Review

Barclays sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q1 2015, closing a stake of 113,353 shares — an estimated $2.04M sold.

Barclays first reported a position in RNA in Q4 2013 and held it in 4 quarters. The position peaked at $2.04M in Q4 2014. 0 funds tracked by Wall St. Rank hold RNA as of Q1 2015.

Barclays reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q1 2015 after selling out during the quarter.
Barclays sold 113,353 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q1 2015, an estimated $2.04M.
Barclays first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q4 2013 and held it in 4 quarters.
Barclays's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $2.04M in Q4 2014.
0 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.